双能CT小肠造影碘密度用于克罗恩病表型分析
本研究回顾性纳入50例克罗恩病患者,采用双源双能CT小肠造影测量病变小肠黏膜的碘密度(I)及主动脉归一化碘密度(I%),并与SAR-AGA共识定义的疾病表型进行比较。结果显示I和I%在不同表型组间存在显著差异,I随表型严重程度增加而升高,穿透性疾病则降低,提示碘密度可用于克罗恩病表型评估。
要点
- 双能CT小肠造影测量的碘密度可区分克罗恩病不同表型。
- 碘密度(I)在狭窄伴活动性炎症组最高,穿透性疾病组降低。
- 归一化碘密度(I%)在活动性炎症及狭窄组均显著高于无活动炎症组。
局限性
- 回顾性研究,样本量较小(50例)。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare dual-source dual-energy CT enterography (dsDECTE) obtained iodine density (I) (mg/mL) and I normalized to the aorta (I%) with Crohn's disease (CD) phenotypes defined by the SAR-AGA small bowel CD consensus statement.
METHODS: Fifty CD patients (31 male, 19 female; mean [SD] age: 50.4 [15.2] years) who underwent dsDECTE were retrospectively identified. Two abdominal radiologists assigned CD phenotypes: no active inflammation (group-2), active inflammation without (group-3) or with luminal narrowing (group-4), stricture with active inflammation (group-5), stricture without active inflammation (group-1), and penetrating disease (group-6). Semiautomatic prototype software was used to determine the median I and I% of CD-affected small bowel mucosa for each patient. The means of the I and I% medians were compared among 4 groups ("1 + 2", "3 + 4", "5", "6") using one-way ANOVA (significance level 0.05 for each outcome) for each outcome individually followed by Tukey's range test for pairwise comparisons with adjusted p-values (overall alpha = 0.05).
RESULTS: Mean [SD] I was 2.14 [1.07] mg/mL for groups 1 + 2 (n = 16), 3.54 [1.71] mg/mL for groups 3 + 4 (n = 15), 5.5 [3.27] mg/mL for group- "5" (n = 9), and 3.36 [1.43] mg/mL for group-"6" (n = 10) (ANOVA p = .001; group "1 + 2" versus "5" adj-p = .0005). Mean [SD] I% was 21.2 [6.13]% for groups 1 + 2, 39.47 [9.71]% for groups 3 + 4, 40.98 [11.76]% for group-5, and 35.01 [7.58]% for group-6 (ANOVA p < .0001; groups "1 + 2" versus "3 + 4" adj-p < .0001, group "1 + 2" versus "5" adj-p < .0001, and groups "1 + 2" versus "6" adj-p = .002).
CONCLUSION: Iodine density obtained from dsDECTE significantly differed among CD phenotypes defined by SAR-AGA, with I (mg/mL) increasing with phenotype severity and decreasing for penetrating disease. I and I% can be used to phenotype CD.
引用
- Dane, Li, Goldberg, et al. Crohn's disease phenotype analysis with iodine density from dual-energy CT enterography. Abdom Radiol (NY). 2023. PMID: 37097450. doi:10.1007/s00261-023-03923-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。